Effects of galantamine in a 2-year, randomized, placebo-controlled study in Alzheimer’s disease

gan Hager, Klaus, Baseman, Alan S, Nye, Jeffrey S, Brashear, H Robert, Han, John, Sano, Mary, Davis, Bonnie, Richards, Henry M
Cyhoeddwyd 2014

Effect of concomitant use of memantine on mortality and efficacy outcomes of galantamine-treated patients with Alzheimer’s disease: post-hoc analysis of a randomized placebo-contro...

gan Hager, Klaus, Baseman, Alan S., Nye, Jeffrey S., Brashear, H. Robert, Han, John, Sano, Mary, Davis, Bonnie, Richards, Henry M.
Cyhoeddwyd yn Alzheimers Res Ther (2016)

First-In-Human safety and long-term exposure data for AAB-003 (PF-05236812) and biomarkers after intravenous infusions of escalating doses in patients with mild to moderate Alzheim...

gan Delnomdedieu, Marielle, Duvvuri, Sridhar, Li, David Jianjun, Atassi, Nazem, Lu, Ming, Brashear, H. Robert, Liu, Enchi, Ness, Seth, Kupiec, James W.
Cyhoeddwyd yn Alzheimers Res Ther (2016)

Amyloid-related imaging abnormalities-haemosiderin (ARIA-H) in patients with Alzheimer's disease treated with bapineuzumab: a historical, prospective secondary analysis

gan Arrighi, H Michael, Barakos, Jerome, Barkhof, Frederik, Tampieri, Donatella, Jack, Clifford, Melançon, Denis, Morris, Kristen, Ketter, Nzeera, Liu, Enchi, Brashear, H Robert
Cyhoeddwyd yn J Neurol Neurosurg Psychiatry (2016)

The effect of galantamine on brain atrophy rate in subjects with mild cognitive impairment is modified by apolipoprotein E genotype: post-hoc analysis of data from a randomized con...

gan Prins, Niels D, van der Flier, Wiesje A, Knol, Dirk L, Fox, Nick C, Brashear, H Robert, Nye, Jeffrey S, Barkhof, Frederik, Scheltens, Philip
Cyhoeddwyd yn Alzheimers Res Ther (2014)

Suicidal ideation and behavior assessment in dementia studies: An Internet survey

gan Chappell, Phillip, Dubrava, Sarah, Stewart, Michelle, Hartley, Dean M., Alphs, Larry, Brashear, H. Robert, Conwell, Yeates, Miller, David, Schindler, Rachel J., Siemers, Eric R., Yaffe, Kristine
Cyhoeddwyd yn Alzheimers Dement (N Y) (2016)

Alzheimer's disease assessment scale-cognitive 11-item progression model in mild-to-moderate Alzheimer's disease trials of bapineuzumab

gan Samtani, Mahesh N., Xu, Steven X., Russu, Alberto, Adedokun, Omoniyi J., Lu, Ming, Ito, Kaori, Corrigan, Brian, Raje, Sangeeta, Brashear, H. Robert, Styren, Scot, Hu, Chuanpu
Cyhoeddwyd yn Alzheimers Dement (N Y) (2015)

Alzheimer's disease progression model using disability assessment for dementia scores from bapineuzumab trials

gan Xu, Steven X., Samtani, Mahesh N., Russu, Alberto, Adedokun, Omoniyi J., Lu, Ming, Ito, Kaori, Corrigan, Brian, Raje, Sangeeta, Brashear, H. Robert, Styren, Scot, Hu, Chuanpu
Cyhoeddwyd yn Alzheimers Dement (N Y) (2015)

Long-term safety and tolerability of atabecestat (JNJ-54861911), an oral BACE1 inhibitor, in early Alzheimer’s disease spectrum patients: a randomized, double-blind, placebo-contro...

gan Novak, Gerald, Streffer, Johannes Rolf, Timmers, Maarten, Henley, David, Brashear, H. Robert, Bogert, Jennifer, Russu, Alberto, Janssens, Luc, Tesseur, Ina, Tritsmans, Luc, Van Nueten, Luc, Engelborghs, Sebastiaan
Cyhoeddwyd yn Alzheimers Res Ther (2020)

Long-term safety and tolerability of bapineuzumab in patients with Alzheimer’s disease in two phase 3 extension studies

gan Ivanoiu, Adrian, Pariente, Jérémie, Booth, Kevin, Lobello, Kasia, Luscan, Gerald, Hua, Lisa, Lucas, Prisca, Styren, Scot, Yang, Lingfeng, Li, David, Black, Ronald S., Brashear, H. Robert, McRae, Thomas
Cyhoeddwyd yn Alzheimers Res Ther (2016)

The pathway to secondary prevention of Alzheimer's disease

gan McDade, Eric, Bednar, Martin M., Brashear, H. Robert, Miller, David S., Maruff, Paul, Randolph, Christopher, Ismail, Zahinoor, Carrillo, Maria C., Weber, Christopher J., Bain, Lisa J., Hake, Ann Marie
Cyhoeddwyd yn Alzheimers Dement (N Y) (2020)

Considerations for the assessment of suicidal ideation and behavior in older adults with cognitive decline and dementia

gan Alphs, Larry, Brashear, H. Robert, Chappell, Phillip, Conwell, Yeates, Dubrava, Sarah, Khin, Ni A., Kozauer, Nicholas, Hartley, Dean M., Miller, David S., Schindler, Rachel J., Siemers, Eric R., Stewart, Michelle, Yaffe, Kristine
Cyhoeddwyd yn Alzheimers Dement (N Y) (2016)

Amyloid Related Imaging Abnormalities (ARIA) in Amyloid Modifying Therapeutic Trials: Recommendations from the Alzheimer’s Association Research Roundtable Workgroup

gan Sperling, Reisa A., Jack, Clifford R., Black, Sandra E., Frosch, Matthew P., Greenberg, Steven M., Hyman, Bradley T., Scheltens, Philip, Carrillo, Maria C., Thies, William, Bednar, Martin M., Black, Ronald S., Brashear, H. Robert, Grundman, Michael, Siemers, Eric R., Feldman, Howard H., Schindler, Rachel J.
Cyhoeddwyd 2011

Findings of Efficacy, Safety, and Biomarker Outcomes of Atabecestat in Preclinical Alzheimer Disease: A Truncated Randomized Phase 2b/3 Clinical Trial

gan Sperling, Reisa, Henley, David, Aisen, Paul S., Raman, Rema, Donohue, Michael C., Ernstrom, Karin, Rafii, Michael S., Streffer, Johannes, Shi, Yingqi, Karcher, Keith, Raghavan, Nandini, Tymofyeyev, Yevgen, Bogert, Jennifer, Brashear, H. Robert, Novak, Gerald, Thipphawong, John, Saad, Ziad S., Kolb, Hartmuth, Rofael, Hany, Sanga, Panna, Romano, Gary
Cyhoeddwyd yn JAMA Neurol (2021)

Bapineuzumab for mild to moderate Alzheimer’s disease in two global, randomized, phase 3 trials

gan Vandenberghe, Rik, Rinne, Juha O., Boada, Mercè, Katayama, Sadao, Scheltens, Philip, Vellas, Bruno, Tuchman, Michael, Gass, Achim, Fiebach, Jochen B., Hill, Derek, Lobello, Kasia, Li, David, McRae, Tom, Lucas, Prisca, Evans, Iona, Booth, Kevin, Luscan, Gerald, Wyman, Bradley T., Hua, Lisa, Yang, Lingfeng, Brashear, H. Robert, Black, Ronald S.
Cyhoeddwyd yn Alzheimers Res Ther (2016)

Two Phase 3 Trials of Bapineuzumab in Mild-to-Moderate Alzheimer’s Disease

gan Salloway, Stephen, Sperling, Reisa, Fox, Nick C., Blennow, Kaj, Klunk, William, Raskind, Murray, Sabbagh, Marwan, Honig, Lawrence S., Porsteinsson, Anton P., Ferris, Steven, Reichert, Marcel, Ketter, Nzeera, Nejadnik, Bijan, Guenzler, Volkmar, Miloslavsky, Maja, Wang, Daniel, Lu, Yuan, Lull, Julia, Tudor, Iulia Cristina, Liu, Enchi, Grundman, Michael, Yuen, Eric, Black, Ronald, Brashear, H. Robert
Cyhoeddwyd 2014

Amyloid-β (11)C-PiB-PET imaging results from 2 randomized bapineuzumab phase 3 AD trials

gan Liu, Enchi, Schmidt, Mark E., Margolin, Richard, Sperling, Reisa, Koeppe, Robert, Mason, Neale S., Klunk, William E., Mathis, Chester A., Salloway, Stephen, Fox, Nick C., Hill, Derek L., Les, Andrea S., Collins, Peter, Gregg, Keith M., Di, Jianing, Lu, Yuan, Tudor, I. Cristina, Wyman, Bradley T., Booth, Kevin, Broome, Stephanie, Yuen, Eric, Grundman, Michael, Brashear, H. Robert
Cyhoeddwyd yn Neurology (2015)